BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23959724)

  • 1. Several statins increase body and liver fat accumulation in a model of metabolic syndrome.
    Aguirre L; Hijona E; Macarulla MT; Gracia A; Larrechi I; Bujanda L; Hijona L; Portillo MP
    J Physiol Pharmacol; 2013 Jun; 64(3):281-8. PubMed ID: 23959724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress.
    Gómez-Zorita S; Fernández-Quintela A; Macarulla MT; Aguirre L; Hijona E; Bujanda L; Milagro F; Martínez JA; Portillo MP
    Br J Nutr; 2012 Jan; 107(2):202-10. PubMed ID: 21733326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid metabolism in adipose tissue and liver from diet-induced obese rats: a comparison between Wistar and Sprague-Dawley strains.
    Miranda J; Eseberri I; Lasa A; Portillo MP
    J Physiol Biochem; 2018 Nov; 74(4):655-666. PubMed ID: 30411231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased de novo lipogenesis in liver contributes to the augmented fat deposition in dexamethasone exposed broiler chickens (Gallus gallus domesticus).
    Cai Y; Song Z; Zhang X; Wang X; Jiao H; Lin H
    Comp Biochem Physiol C Toxicol Pharmacol; 2009 Aug; 150(2):164-9. PubMed ID: 19393339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bifidobacterium adolescentis supplementation ameliorates visceral fat accumulation and insulin sensitivity in an experimental model of the metabolic syndrome.
    Chen J; Wang R; Li XF; Wang RL
    Br J Nutr; 2012 May; 107(10):1429-34. PubMed ID: 21914236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
    Liu LF; Purushotham A; Wendel AA; Belury MA
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
    Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care.
    Harley CR; Gandhi SK; Heien H; McDonough K; Nelson SP
    Expert Opin Pharmacother; 2008 Apr; 9(5):669-76. PubMed ID: 18345946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological comparison of the statins.
    Klotz U
    Arzneimittelforschung; 2003; 53(9):605-11. PubMed ID: 14558433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database.
    Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Davidson MH
    Clin Ther; 2007 Nov; 29(11):2385-94. PubMed ID: 18158079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies.
    Glueck CJ; Aregawi D; Agloria M; Khalil Q; Winiarska M; Munjal J; Gogineni S; Wang P
    Clin Ther; 2006 Jun; 28(6):933-42. PubMed ID: 16860175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update.
    Schachter M
    Fundam Clin Pharmacol; 2005 Feb; 19(1):117-25. PubMed ID: 15660968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in hepatic lipogenic and oxidative enzymes and glucose homeostasis induced by an acetyl-L-carnitine and nicotinamide treatment in dyslipidaemic insulin-resistant rats.
    Ferreira MR; Camberos Mdel C; Selenscig D; Martucci LC; Chicco A; Lombardo YB; Cresto JC
    Clin Exp Pharmacol Physiol; 2013 Mar; 40(3):205-11. PubMed ID: 23278446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which statin is most efficient for the treatment of hypercholesterolemia? A cost-effectiveness analysis.
    Cobos A; Jovell AJ; García-Altés A; García-Closas R; Serra-Majem L
    Clin Ther; 1999 Nov; 21(11):1924-36. PubMed ID: 10890264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic action of peroxisome proliferator-activated receptor gamma agonism in rats with exogenous hypercorticosteronemia.
    Berthiaume M; Laplante M; Tchernof A; Deshaies Y
    Int J Obes (Lond); 2007 Nov; 31(11):1660-70. PubMed ID: 17579631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins and new-onset diabetes: a retrospective longitudinal cohort study.
    Ma T; Tien L; Fang CL; Liou YS; Jong GP
    Clin Ther; 2012 Sep; 34(9):1977-83. PubMed ID: 22939164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review with network meta-analysis: statins and risk of hepatocellular carcinoma.
    Zhou YY; Zhu GQ; Wang Y; Zheng JN; Ruan LY; Cheng Z; Hu B; Fu SW; Zheng MH
    Oncotarget; 2016 Apr; 7(16):21753-62. PubMed ID: 26943041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alleviation of hepatic steatosis accompanied by modulation of plasma and liver TNF-alpha levels by Trigonella foenum graecum (fenugreek) seeds in Zucker obese (fa/fa) rats.
    Raju J; Bird RP
    Int J Obes (Lond); 2006 Aug; 30(8):1298-307. PubMed ID: 16477270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE; Feely J; Sigurdsson EL;
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.